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Abstract
The last review on Tick-borne encephalitis (TBE) in dogs was published almost ten years ago. Since then, this
zoonotic tick-borne arbovirus has been geographically spreading and emerging in many regions in Eurasia and
continues to do so. Dogs become readily infected with TBE virus but they are accidental hosts not capable to
further spread the virus. They seroconvert upon infection but they seem to be much more resistant to the clinical
disease than humans. Apart from their use as sentinels in endemic areas, however, an increasing number of case
reports appeared during the last decade thus mirroring the rising public health concerns. Owing to the increased
mobility of people travelling to endemic areas with their companion dogs, this consequently leads to problems in
recognizing and diagnosing this severe infection in a yet non-endemic area, simply because the veterinarians are
not considering TBE. This situation warrants an update on the epidemiology, clinical presentation and possible
preventions of TBE in the dog.
Introduction and epidemiology of TBE
Tick-borne encephalitis (TBE) is the most important
tick-borne viral disease of humans in Eurasia with an
estimated annual number up to 10,000 cases in Russia
and 3,000 cases in Europe [1-5]. TBE is caused by the
zoonotic tick-borne encephalitis virus (TBEV), a mem-
ber of the genus Flavivirus within the Flaviviridae
family [6]. It is classified as a single virus species with
three subtypes, i.e. the European subtype, the Siberian
subtype (mainly isolates east of the Ural and Siberia)
and the Far Eastern subtype (mainly isolates from far-
eastern Russia, China and Japan) together representing
the geographic distribution of the virus [6,7]. The three
TBE virus subtypes are differing with regard to disease
severity [1,8,9]. The most severe form of TBE infections
with Far Eastern subtype TBE viruses can cause severe
febrile illness, frequently associated with encephalitis
and a fatality rate up to 35% [10,11]. In contrast, TBE
virus infections of the Siberian subtype cause a less
severe disease (fatality rate between 1 and 3%). However,
these clinical infections have a tendency to become a
chronic disease or to cause extremely prolonged infec-
tions in some patients [12,13]. Infections caused by Eur-
o p e a ns t r a i n st y p i c a l l yt a k eab i p h a s i cc o u r s e .T h ef i r s t
viraemic phase presents with fever, malaise, headache,
myalgia, sometimes gastrointestinal symptoms, leukocy-
topenia, thrombocytopenia and elevated liver enzymes
after an incubation period of one to two weeks. These
non-specific symptoms last for about 2-4 days, often fol-
lowed by a symptom-free interval of up to one week.
The second phase of TBE occurs in approximately one-
quarter of the infected patients and shows the clinical
signs of meningitis, meningoencephalitis, meningoence-
phalomyelitis or meningoencephaloradiculitis of differ-
ent severity. The fatality rate in adult patients is
comparable to that caused by the Siberian subtype TBE
virus, but is usually less than 2%. However, neurological
sequelae may last for months or even years [14].
TBE virus is propagated in nature in a transmission
cycle consisting of permanently infected tick vectors and
wild vertebrate hosts [15]. Within the tick population,
the virus is maintained in a transstadial fashion and pos-
sibly to a small extent via transovarial transmission to
the next developmental stage of the tick’s life cycle.
Small mammals (mainly rodents), on which larvae,
nymphs and adults feed, become infected during the
blood meals (Figure 1). Once infected, they serve as
v i r u sr e s e r v o i r s ,f r o mw h i c hT B Ev i r u si sf u r t h e r
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mia of the rodent, or (ii) through co-feeding from
infected to non-infected ticks feeding on the same host
a tt h es a m et i m e[ 1 6 - 1 8 ] .I na d d i t i o n ,T B Ev i r u st r a n s -
mission to humans by raw milk consumption has
repeatedly caused clusters of human cases [19-24].
The European TBE virus strains are almost exclusively
vectored by Ixodes ricinus while I. persulcatus serves as
vector for the two other subtypes [25,26]. Although the
virus has been isolated from several other tick species in
nature [27,28], only the two mentioned ixodid tick spe-
cies appear to play an important role in virus mainte-
nance [17]. Dermacentor nuttalli,h o w e v e r ,m a ys h a r e
this role in southern Siberia and northern Mongolia
(unpublished results). Nevertheless, the epidemiology of
TBE is tightly linked to the local national history of ixo-
did ticks [1,4,9,25,29], and the prevalence of infected
ticks within the risk areas can vary considerably
[1,8,25,29,30]. Countries with high-risk areas (incidence
of clinical TBE cases is > 10 per 10
5 inhabitants) are
Russia, Latvia, Lithuania, Slovenia, and Estonia. TBE is
also a significant issue in Germany, the Czech Republic,
Poland, Switzerland, Sweden, Finland, Slovakia, and
Hungary [31,32]. Although TBE seems to have a minor
public health impact in Denmark, France, Greece, Italy
and Norway, new TBE foci or possible occurrences of
TBE virus were reported here [33-37]. Austria is the
only country with progressively decreasing incidences
since 1981 due to its vaccination policy [38], but the
occurrence of TBE may be relevant to unvaccinated
tourists and their accompanying dogs. There are only
few studies investigating the TBE prevalence in domestic
animals and even less including dogs [39-41].
The last review on Tick-borne encephalitis (TBE) in
dogs was published almost ten years ago [42]. In light of
the increase of TBE incidence that has been observed in
the risk areas in some of the endemic countries men-
tioned above [4], we feel it warranted to review the
Ixodes ricinus
Ixodes spp.
transovarial
transmission:
low importance
transstadial
transmission
transstadial
transmission
? (rarely)
Figure 1 Schematic drawing of the transmission cycle of tick-borne encephalitis virus. The dog can serve as host for all three life stages
of the Ixodes tick, i.e. the larvae, the nymph and the adult tick. As with humans it is rather the nymphs and even more numerous the adults
that feed on dogs. The alimentary infection of humans via TBE virus-contaminated milk is also shown. Although this frequently causes clusters of
infection in humans, we are not aware of such an infection route for dogs.
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future research.
Dogs, ticks and TBE
Tick infestation in dogs is a well recognized world-wide
problem. The Ixodidae alone compromise 702 tick spe-
cies in 14 genera [43], but not all of them parasitize
dogs. Depending on the geographic area, the tick species
associated with dogs differ considerably. In North Amer-
ica, for example, virtually all ticks found on dogs are
brown dog ticks (Rhipicephalus sanguineus), American
dog ticks (Dermacentor variabilis), Rocky Mountain
wood ticks (D. andersoni), Western dog ticks (D. occi-
dentalis), Lone Star ticks (Amblyomma americanum),
Gulf Coast ticks (A. maculatum), deer ticks (Ixodes
dammini), blacklegged ticks (I. scapularis), and wood-
chuck ticks (I. cookei) [44,45]. Studies from northern
Brazil further demonstrate that the tick species compo-
sition varies between urban dogs (exclusively R. sangui-
neus infested) and dogs from rural areas (at least four
species including R. sanguineus) [46,47]. As outlined
above, none of the previously listed tick species is
involved in the natural transmission of TBE virus,
because TBE virus is not yet prevalent in these regions.
However, I. cookei and I. scapularis were shown to be
naturally infected with the closely related Powassan
virus in North America [48,49]. Experimental data on
transmission potential and vector capacity of ticks exclu-
sively occurring in the New World are not available for
TBE virus. The most abundant ticks in northern Europe,
the castor bean tick, I. ricinus, and the Taiga tick, I. per-
sulcatus, are transmitting TBE virus. Both of them para-
sitize dogs. In Japan, I. ovatus, another Ixodes tick
species frequently feeding on dogs, is supposed to vector
TBE virus [50]. With their furry coats, the close proxi-
mity to the ground and their behavior in seeking and
exploring, dogs are 50 to 100 times more likely to come
in contact with disease-carrying ticks than humans [51].
Walking the dog and leisure activity has been identified
as important risk factors for humans to aquire a TBE
virus infection [25,52]. Being a dog owner in an endemic
area is thus enhancing the risk to be bitten by a tick,
simply because of the time spent outdoors and the
increased exposure when compared with people not reg-
ularly walking a dog. In addition, ticks attached to the
dogs are brought home where they may infest humans,
in particular children, who are also playing with the ani-
mals indoors. Meanwhile TBE has become an accepted
issue in human travel medicine [53,54]. Since the estab-
lishment of the EU, traveling between European (and to
some extent to Eurasian) countries has become much
easier and millions of holiday or business tourists from
non-endemic countries are visiting endemic areas within
the time of the year when ticks are active and
transmission of TBE virus can occur. While an increas-
ing but still small percentage of these people consider to
get vaccinated against TBE, none is aware of the fact
that the accompanying dogs are much more likely to
become infected due to the reasons outlined above [54].
Clinical signs and Diagnosis
Based on the few case reports available (see Table), TBE
manifests with almost the identical symptoms as seen in
clinical human cases. However, the clinical cases seen in
dogs, which are later confirmed in the laboratory as
TBE, present as very severe and have almost exclusively
a fatal outcome. Incubation period is supposed to equal
the one known for humans and thus is supposed to be
between one and two weeks. However, because clinical
TBE is rarely diagnosed, this period is an estimate made
in analogy from the human situation, but since even
experimental infections of puppies usually do not result
in clinical illness [55], the incubation period in dogs
m a yb es h o r t e rt h a no n eo rl o n g e rt h a nt w ow e e k s .
Detailed descriptions of the clinical development have
been published [56-60]. Common in the clinical course
of TBE in dogs is the elevated body temperature (up to
41.4°C) and change in behavior (denying food, increased
aggressiveness, skittishness or apathia). All ill dogs
showed motor failures either on the forhand or the rear
legs with retarded proprioception and hyporeflexy in
front and/or rear legs. More detailed clinical inspection
with neurological examination reveals paresis, mostly
tetraparesis, to generalized ataxia and tetraplegia, myo-
clonus, vestibular syndrome (Strabismus), sensibility loss
in the head area but cervical hyperalgesia, facial nerve
paralysis, anisocoria, nystagmus, miosis or loss of eye lid
closing reflex (see Table 1). These signs reflect the mul-
tifocal neurological disorder in the cerebrum and the
brain stem. A single case description links TBE as possi-
ble cause of optic neuritis in a Siberian Husky [61].
Since clinical signs vary, laboratory confirmation of
the etiological agent causing the encephalitic outcome is
needed. Haematology may show physiological leucocyte
counts, but the differential blood count may indicate a
monocytosis and a lymphopenia or a leucopenia with
physiological counts of both monocytes and lympho-
cytes [58]. Elevated total leucocyte and mononuclear cell
counts as well as high protein concentration in the
liquor are typical indicators for an encephalitis and are
commonly described in cases of clinical TBE in the dog
[58,59].
S p e c i f i cd i a g n o s t i cp r o c e d u res to confirm clinically
suspected TBE include dete c t i o no fT B Ev i r u si nt h e
serum during viremia by one of the many published
RT-PCRs or real-time RT-PCRs [e.g. 62]. Viral antigen
can also be detected by immunohistopathology of brain
tissues after necropsy [60,63]. In most cases, the initial
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Year Animal species
a Clinincal symptoms Viremia?
b Reference-
location
Ab-response?
c
Experimental infections
1946 Wolf puppies i.c. Paresis, convulsions, encephalitis, death Virus isolation [70] High Ab-titers
1956 Adult foxes i.c. No clinic n.d. [71] n.d.
1958 Fox puppies Fever viremia [72] High Ab-titers
1959 Dog i.n. encephalitis n.d. [73] n.d.
1969 Foxes, badgers, weasels
via Ixodes ricinus
Meningencephalitis (foxes) yes [74] n.d.
1972 Dog puppies s.c. and via
Haemaphysalis inermis
and Dermacentor
marginatus ticks
No clinic in puppies infected via tick,
weakness in extremities in s.c. infected
puppies
Low level
viremia found
irregularly
[55] Yes
Natural infections
1960 n.d. Encephalitis n.d. [75]
Sweden
Yes (first documented clinical case of
TBE in a dog)
1970 1 Landseer (4.5 years old) Aggressiveness, fever, tremor paresis,
meningitis, seizures, cramp of front legs
Yes (first isolate
form a dog
after natural
infection)
[56,76]
Switzerland
n.d.
1993 5 dogs (2 Rottweiler, 1
Greyhound, 1 Husky, 1
Golden Retriever)
Ataxia, tetraparesis, fever, seizures of
grand male-type
n.d. [60]
Switzerland
IgM in CSF in 2 dogs. All were
euthanized and diagnoses were
confirmed by IHC
1994-
1997
3 Husky, 1 Terrier-mix, 1
Rottweiler, 1 Irish setter, 1
Bastard, 1 Pekingese
Convulsion, tremor, ataxia,
hyperesthesia, hemi-/tetraplegia,
recumbency, opisthotonus, seizures,
anisocoria, miosis, nystagmus
n.d. [63] Austria Immunohistology in brain tissue
positive in 5 dogs, but
pathohistological changes were similar
in the remaining three dogs
1998 1 Rottweiler (4 years old),
1 Newfoundland dog (6
years old)
Fever, hyperaesthesia, seizures
opistotonus, facialparesis, strabismus,
sensoric loss (head)
n.d. [58]
Germany
Yes (both dogs)
2001 1 (Riesenschnauzer, 2.5
years old)
Fever, aggressiveness, ataxia, shivering n.d. [77]
Sweden
Yes
2002 1 dog Fever, ataxia, shivering, agressivness,
quadriplegia
n.d. [77]
Sweden
Yes
2006 1 dog Ataxia, tremor, sensoric loss n.d. [78]
Sweden
Yes
2007 2 dogs Fever, ataxia, tremor, pain, head
shaking. Both fully recovered after 1
year
n.d. [79]
Sweden
Yes
2009 1 mix-breed (12 years old) Polypneu, ataxia, weakness, diffuse pain
(euthanized)
n.d. [80] Italy n.d. (PCR and IHC of brain tissue
positive)
Serosurveillance studies
1988-
1991
255 No clinic n.d. [81]
Sweden
18 seropositive
1993-
1998
About 1.000 dogs No clinic relating to CNS symptoms n.d. [64]
Germany
Between < 2% (northern states) and
31% (Bodensee area)
1994
&
1995
10 sentinel dogs each
year (Ixodes ovatus)
No clinic 3 virus isolates,
Far-Eastern
subtype
[50] Japan Japan, high Ab-titers upon
seroconversion
1997-
1998
151 dogs In three Rottweiler dogs with
meningoencephalitis or encephalitis
n.d. [59] Czech
Republic
5 seropositive (3.3%)
1999 552 dogs Clinical signs in 57 of the seropositive
dogs
n.d. [66] Austria 133 seropositive (24.1%, ELISA); 110
confirmed by NT (19.9%)
1998-
2003
317 dogs Not observed n.d. [82]
Southern
Norway
52 seropositive (16.4%)
2002 54 healthy & 56 dogs
with neurological
symptoms
Neurological symptoms not further
specified
n.d. [83]
Germany
17/54 seropositive; 30/56 seropositive
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tic will probably be requested too late after the infection
to detect virus. Hence, laboratory confirmation of TBE
is mostly done by serology. Antibody titers against TBE
virus can be measured either by indirect immunofluor-
escence assays (IFA, Euroimmune, Lübeck, Germany) or
an all-species ELISA (Progen Biotechnik GmbH, Heidel-
berg, Germany). Detection of IgM or the four-fold rise
in IgG antibodies in a serum pair taken about two
weeks apart confirms the diagnosis. Serology in flaviviral
infections in humans is notoriously hampered by cross-
reactivity between other infections or vaccinations such
as dengue-, Japanese encephalitis- or yellow fever
viruses. In the case of dogs, the only possible cross-reac-
tivity which may interfere with the serological confirma-
tion of a TBE case could be an infection of the dog with
West Nile virus (WNV), another flavivirus that has a
growing geographic range in Eurasia and which is par-
tially overlapping with the known distribution of TBE.
However, dogs do not become readily infected with
WNV, so at least to what is known to date, serological
diagnosis of TBE in dogs is confirmative.
Another issue to be considered in serodiagnosing TBE
i st h a to n l yar i s ei nt h es p e c i f i ca n t i b o d yt i t r e si np a i r e d
sera is conclusive when seroprevalence rates of more
than 30% are known in endemic areas [64]. Although not
particularly shown for dogs in endemic areas, it is known
from cattle in Hungary that animals of older age groups
have significantly higher seroprevalence rates than those
of younger age groups. This could either argue for long-
evity of TBE virus-specific antibodies or a higher fre-
quency of encountering TBE virus-infected ticks over
time [40]. However, whether this applies to dogs as well
and thus has to be kept in mind while verifying the diag-
nosis serologically is not known and might be subject of
further studies. Nevertheless, there is no case definition
formulated for TBE in dogs, but positive serological
results in conjunction with time spent in known endemic
areas is what we consider a confirmed case. The known
h i s t o r yo ft i c kb i t e si saf u r t h er epidemiological link, but
not necessary for confirming the diagnosis. This is mainly
because dogs are supervised and inspected with different
intensities and thus ticks may easily be overlooked.
Pathology, Treatment and Prevention
The dominating pathological picture is that of a massive
encephalitis while visceral organs are without gross lesions
or histopathological findings. The meningoencephalitis is
non-suppurative and characterized by necrosis of both
neurons and glia cells. Almost the entire brain shows typi-
cal signs of inflammation like perivascular cuffs and infil-
tration (lymphocytes, histiocytes and plasma cells),
neuronophagy, glial nodules or diffuse gliosis [60,63].
Pathological changes were most prominent in the brain
stem and the cerebellum [65]. Based on the probably most
comprehensive investigation by Kirtz in 1999 [66], the
neurostructures related to the clinical symptoms are the
thalamus (66%, fever and 54% altered consciousness and
behavior), the cerebral cortex (54%, the same symptoms as
above), the mesencephalon (42%, proprioceptive deficit),
the spinal cord (37%, motor neuron deficit), meninges
(21%, hyperalgesia in the neck), brainstem (20%, head tilt,
facial paresis, nystagmus, strabismus), cerebral cortex and
thalamus (12%, seizures). Taken together, the neuro-
pathology of TBE in dogs is largely consistent with the
neuropathology of TBE in humans [63].
Because no causal treatment exists to fight TBE, treat-
ment is solely symptomatic. Emphasis has to be put on
preventing secondary harm to the patient itself as well
as the owner during convulsions and aggressive beha-
vior. For that reason, therapy should include resting as
well as anticonvulsive and sedative medication. The
application of dexamethasone and its possible beneficial
effect is controversially discussed: given too early in the
course of infection, the glucocorticoide may prolong the
destructive viral activity, but when administered during
the reconvalence phase, a fast decline of symptoms was
observed [60,66]. Non-steroidal anti-inflammatory drugs
(NSAID) are best used to combat the high fever, and
antibiotics should be given to prevent secondary bacter-
ial infections, in particular pneumonia [57]. Most of the
few dogs, that survived a clinical TBE needed between a
half and one year to fully recover. As with in human
cases, an intensive physical therapy seems to be a key
issue in the process of training and compensating the
loss of neuronal damage caused by the severe inflamma-
tion of the central nervous system.
Table 1 Tick-borne encephalitis virus in Carnivora and Canidae (Continued)
2005-
2006
125 dogs Not observed n.d. [39]
Denmark
30% ELISA-, 4.8% NT-antibodies
2009 960 dogs Not observed n.d. [84]
Belgium
d
1 seropositive (0.1%)
d
a = infection routes: i.c., intra cranial; i.n., = intra nasal; s.c.; = sub cutaneous
b = n.d., not determined
c = Ab, antibody; ELISA = enzyme-linked immunosorbent assay; NT = neutralization test; IHC = immunohistochemistry
d = Belgium is still considered to be non-endemic for TBE. A travel history of the seropositive dog to endemic areas in France and Germany may explain this
result.
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and they are primarily targeting the prevention of tick
bites. One problem when dealing with three-host ticks
(Figure 1) is the fact that the majority of reproducing
ticks is not feeding on the dog but rather on wildlife
hosts. As we are limited in our ability to manage ticks
on their “natural” hosts, reinfestation of dogs is common
requiring protracted use of acaricides [67]. There are
many powerful anti-ectoparasite drugs with acaricide
function of up to four weeks on the market, which can
be easily applied in a spot-on or pour-on by the dog
owner. Since a dog needs to be walked, this is the most
effective way to prevent infection via ticks in an ende-
mic area. Numerous studies have shown the often excel-
lent efficacy of products containing acaricides such as
amitraz, fipronil, and permethrin against ticks infesting
dogs [reviewed in [67]]. If a dog is treated with an effec-
tive acaricide, and encounters only a few ticks, it is likely
that all these ticks will be killed. However, if tick expo-
sure is considerably larger, a few ticks may still be
remaining on these dogs and, when observed by pet
owners, they may perceive a lack of efficacy. One of the
most commonly practiced solutions to this problem is
to increase the frequency of acaricide application on the
dog [67]. Since the current classes of acaricides, which
are orders of magnitude less toxic for the dog and the
environment than formerly used DDT or lindane formu-
lations, this practice does not cause harm to the dog
patient. Topical application also reduces systemic levels
of the active ingredients and is localized directly on the
skin, the critical interface for bloodsucking ticks [68].
The costs and benefits of regularly using topicals to
reduce tick infestation needs to comprise the estimated
and potential burden of ill health due to TBE virus
infection and other tick-borne diseases or owner atti-
tudes towards ectoparasitism as well as the estimated
burden due to the documented attributable toxic effects
o ft h ep r e v e n t a t i v ec o m p o und [68]. Although it still
seems that clinical TBE in dogs is a rare event, such an
analysis is likely to conclude that the benefits of topicals
outweigh their slight risk of toxicity.
In Europe, there are currently two vaccines licensed
for human use, including special formulations or vacci-
nation schemes for infants and older patients. None of
the two companies (Novartis and Baxter) has their TBE
vaccines licensed for any animal use including dogs.
However, vaccines from both companies have been suc-
cessfully used to vaccinate various animal species (e.g.
sheep, goat, roe deer, dogs) without any adverse effect.
Antibody titers measured either in IFA or ELISA sug-
gest, that in all cases, a protective immune response was
induced through vaccination with human vaccines (69,
M. Niedrig, RKI, Berlin, pers. communication, own
unpublished results). Hence, vaccination of dogs should
be considered an effective preventive measure in highly
endemic areas.
Conclusion
Seroprevalence studies in areas of Eurasia where TBE
virus is endemic clearly show that dogs are highly suscep-
tible to an infection. For yet unknown reasons, clinical
manifestation seems to be a rare event, but then likely to
have a fatal outcome. Increasing numbers of case reports
describing clinical TBE in dogs are found in the recent
literature with some coming from previously non-ende-
mic areas. This raises concerns with regard to a further
geographical expansion of TBE virus-endemic areas, an
increasing prevalence of TBE virus in the vector ticks
and/or a change in virulence of the TBE virus strains
involved. Regardless of the underlying reasons, these
observations have implications for travel medicine in
dogs. One major aim of this article is to raise awareness
of the clinical picture of TBE in dogs so that this diagno-
sis may be considered in cases of neurological disorders
even in yet non-endemic areas, but for example in dogs
with a respective travel history. The currently known
TBE virus-endemic areas should be known, so travel
recommendations can be made including the application
of the topical acaricides. Vaccines for human have
impressively demonstrated that the incidence in humans
can be dramatically reduced in highly endemic areas with
the right vaccination policy. First results indicate that
these vaccines can be used in dogs, but comprehensive
studies on the safety and efficacy of the existing human
vaccines in dogs are warranted in order to have alterna-
tive prevention measures at hand when they are needed.
With increasing numbers of TBE cases in humans, a like-
wise increase of such cases in dogs may occur in the near
future. Hence, we should monitor TBE virus infections in
dogs regardless whether they present with clinical signs
or only as a serconversion without an overt clinic.
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